| Helicobacter Pylori |
1 |
1 |
| Noncolorectal Gastrointestinal Cancer |
0 |
0.9 |
| Esophageal Cancer |
0 |
0.99 |
| Otolaryngology |
0 |
0.82 |
| Esophageal Adenocarcinoma |
0 |
0.98 |
| Esophagus |
0 |
0.66 |
| Cancer |
0 |
0.54 |
| Cancer Risk |
0 |
0.51 |
| Gastric Cancer |
0 |
0.42 |
| Squamous Cell Carcinoma |
0 |
0.42 |
| Adenocarcinoma |
0 |
0.3 |
| Gastroesophageal Reflux Disease |
0 |
0.21 |
| Revenue and Practice Management |
0 |
0.08 |
| Proton Pump Inhibitor |
0 |
0.06 |
| Salary and Compensation |
0 |
0.06 |
| Tumor |
0 |
0.06 |